EU Regulators to Review Fibroid Drug for Possible Liver Risk

EU Regulators to Review Fibroid Drug for Possible Liver RiskReports of liver damage and transplants have surfaced regarding ulipristal acetate (Esmya), now before the FDA for approval to treat uterine fibroids.
News AlertsReports of liver damage and transplants have surfaced regarding ulipristal acetate (Esmya), now before the FDA for approval to treat uterine fibroids.
News Alerts
Go to Source
Author:

Powered by WPeMatico